Dual defect in metabolism of very-low-density lipoprotein triglycerides. Patients with type 5 hyperlipoproteinemia.

Transport of very-low-density lipoprotein (VLDL) triglycerides (TGs) were studied in eight patients with type 5 hyperlipoproteinemia (HLP). Results were compared to those from patients with type 4 HLP. Type 4 patients had either overproduction of VLDL TGs (nine patients) or defective clearance of VLDL TGs (eight patients). Patients with type 5 HLP were found to have increased production rates of VLDL TG, but also reduced fractional catabolic rates of VLDL TGs. Synthesis rates of VLDL TGs in type 5 were similar to those in type 4 patients with overproduction of VLDL TGs. The mean fractional catabolic rate in patients with type 5 HLP also were similar to those of type 4 patients with defective clearance. This study demonstrates that in most patients with type 5 HLP there is a dual defect in TG metabolism--overproduction of VLDL TGs and a clearance defect for TG-rich lipoproteins.

[1]  B. Persson.  Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature. , 2009, Acta medica Scandinavica.

[2]  S. Grundy,et al.  Metabolism of Cholesterol and Plasma Triglycerides in Nonketotic Diabetes Mellitus , 1982, Diabetes.

[3]  J. Brunzell,et al.  Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. , 1982, The Medical clinics of North America.

[4]  S. Grundy,et al.  Triglyceride and Cholesterol Metabolism in Primary Hypertriglyceridemia , 1982, Arteriosclerosis.

[5]  M. Taskinen,et al.  High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man--evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[6]  S. Grundy,et al.  Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. , 1981, Journal of lipid research.

[7]  A. Chait,et al.  Heterogeneity of primary lipoprotein lipase deficiency. , 1980, Metabolism: clinical and experimental.

[8]  S. Grundy,et al.  Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects. , 1979, The Journal of clinical investigation.

[9]  S. Grundy,et al.  Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. , 1979, The Journal of clinical investigation.

[10]  L. Carlson,et al.  Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive type V hyperlipoproteinaemia by nicotinic acid treatment. , 1978, Atherosclerosis.

[11]  H. Lithell,et al.  Increase of the lipoprotein‐lipase activity in human skeletal muscle during clof ibrate administration , 1978, European journal of clinical investigation.

[12]  A. Gotto,et al.  Primary type V hyperlipoproteinemia in childhood. , 1977, JAMA.

[13]  W. Blackwelder,et al.  Primary type V hyperlipoproteinemia. A descriptive study in 32 families. , 1977, Annals of internal medicine.

[14]  S. Grundy,et al.  The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia. , 1977, Atherosclerosis.

[15]  P. Bachorik,et al.  The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood. , 1977, Pediatrics.

[16]  J. Huttunen,et al.  Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia. , 1977, Metabolism: clinical and experimental.

[17]  S. Grundy,et al.  Chylomicron clearance in normal and hyperlipidemic man. , 1976, Metabolism: clinical and experimental.

[18]  A. Goldberg,et al.  Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism. , 1976, The Journal of clinical endocrinology and metabolism.

[19]  W. Rascher,et al.  Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia. , 1976, Journal of lipid research.

[20]  J. Huttunen,et al.  Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. , 1976, Clinical science and molecular medicine.

[21]  W. Neuklis,et al.  Structure/Activity Relationship of Gemfibrozil (CI-719) and Related Compounds , 1976, Proceedings of the Royal Society of Medicine.

[22]  J. Brunzell,et al.  Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. , 1975, The Journal of clinical investigation.

[23]  D. Porte,et al.  Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). , 1975, Metabolism: clinical and experimental.

[24]  R. Krauss,et al.  Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. , 1974, The Journal of clinical investigation.

[25]  A. Kissebah,et al.  The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia , 1974, European journal of clinical investigation.

[26]  D. Porte,et al.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. , 1973, The Journal of clinical investigation.

[27]  J. Mendelson,et al.  Alcohol-Induced Hyperlipidemia and Beta Lipoproteins , 1973, Science.

[28]  S. Grundy,et al.  Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. , 1972, Journal of lipid research.

[29]  W. Brown,et al.  Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. , 1972, Biochemical and biophysical research communications.

[30]  H. Wise.  Physicians in health centers. , 1970, Postgraduate medicine.

[31]  D. Porte,et al.  Acute Insulin Withdrawal and the Regulation of Plasma Triglyceride Removal in Diabetic Subjects , 1968, Diabetes.

[32]  R. Lees,et al.  Editorial: A System for Phenotyping Hyperlipoproteinemia , 1965 .

[33]  E. H. Ahrens,et al.  CARBOHYDRATE METABOLISM IN TWO FORMS OF HYPERGLYCERIDEMIA. , 1964, The Journal of clinical investigation.

[34]  K. Isselbacher,et al.  METABOLIC EFFECTS OF ALCOHOL ON THE LIVER. , 1964, The New England journal of medicine.

[35]  S. Grundy,et al.  Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. , 1984, JAMA.

[36]  E. Nikkila.  Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. , 1983 .

[37]  S. Grundy,et al.  Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. , 1981, Journal of lipid research.

[38]  Nash Dt.  Gemfibrozil--a new lipid lowering agent. , 1980 .

[39]  C. Glueck,et al.  Familial and acquired type V hyperlipoproteinemia. , 1976, Atherosclerosis.

[40]  R. Levy,et al.  The current status of hypolipidemic drugs. , 1970, Postgraduate medicine.